ストックスクリーナーアプリを入手
3.56
5.33%
0.18
アフターアワーズ：
3.54
-0.02
-0.56%
前日終値:
$3.38
開ける：
$3.39
24時間の取引高:
36,449
Relative Volume:
1.48
時価総額：
$8.16M
収益：
$2.98M
当期純損益:
$-2.68M
株価収益率:
-2.2034
EPS:
-1.6157
ネットキャッシュフロー:
$-2.29M
1週間 パフォーマンス:
+13.02%
1か月 パフォーマンス:
+5.33%
6か月 パフォーマンス:
-18.91%
1年 パフォーマンス:
+47.72%
1日の値動き範囲:
$3.3319
$3.6799
1週間の範囲:
$2.9452
$3.6799
52週間の値動き範囲:
$1.90
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
名前
Xenetic Biosciences Inc
セクター
電話
781-778-7720
住所
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
3.56 | 7.74M | 2.98M | -2.68M | -2.29M | -1.6157 |
VRTX
Vertex Pharmaceuticals Inc
|
435.65 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.00 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.13 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.70 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-01-08 | 開始されました | Maxim Group | Buy |
Xenetic Biosciences Inc (XBIO) 最新ニュース
Investment Report: Can Xenetic Biosciences Inc maintain sales growth2026 Valuation Update & Breakout Confirmation Alerts - baoquankhu1.vn
Published on: 2026-04-13 21:59:57 - baoquankhu1.vn
History Review: Is Xenetic Biosciences Inc stock good for income investors2026 Patterns & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Sectors Review: Is Xenetic Biosciences Inc stock undervalued right nowTrade Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Loss Report: Is Xenetic Biosciences Inc a potential multi baggerWeekly Risk Report & Risk Controlled Stock Alerts - baoquankhu1.vn
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
XBIO.WS (Xenetic Biosciences) PB Ratio : (As of Apr. 04, 2026) - gurufocus.com
Highs Report: Is now the right time to enter Xenetic Biosciences Inc2026 PreEarnings & Weekly High Conviction Ideas - baoquankhu1.vn
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Short Interest Update - Defense World
Published on: 2026-03-27 18:33:00 - baoquankhu1.vn
Aug Volume: Is Xenetic Biosciences Inc on track to beat earningsQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn
Analyst Calls: Can Xenetic Biosciences Inc be recession proof2026 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Xenetic (XBIO) Reports Increased Revenue and Advances Clinical D - GuruFocus
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Bitget
[8-K] Xenetic Biosciences, Inc. Reports Material Event | XBIO SEC FilingForm 8-K - Stock Titan
Cancer biotech Xenetic grows Takeda royalties to $3M, trims costs - Stock Titan
Xenetic Biosciences: Fourth Quarter Financial Results Overview - Bitget
Xenetic Biosciences 2025 Annual Report: Advancing DNase Immuno-Oncology Technology for Solid Tumors and Strategic Business Developments - Minichart
Xenetic Biosciences: Q4 Earnings Snapshot - KTVB
XBIO: Revenue up 19%, net loss narrows, DNase oncology focus, strategic review underway - TradingView
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
XBIO SEC FilingsXenetic Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Risk On: Can Xenetic Biosciences Inc be recession proofWeekly Profit Summary & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Big Money Moves: Is Xenetic Biosciences Inc stock a value trapJuly 2025 Retail & Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-03-07 03:26:22 - baoquankhu1.vn
Xenetic Biosciences adjourns 2025 annual meeting - MSN
Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn
XBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analyst Downgrade: Can Xenetic Biosciences Inc be recession proofQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn
XBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - Montgomery Advertiser
XBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XBIO Should I Buy - Intellectia AI
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Increase in Short Interest - Defense World
Trading Recap: Is AMKR stock a value trapWeekly Loss Report & Growth Focused Stock Reports - baoquankhu1.vn
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - Independent Mail
Is Xenetic Biosciences Inc stock undervalued right now2025 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
Aug Analyst Calls: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn
Technical Analysis: Is VRMEW affected by consumer sentimentChart Signals & Growth Focused Stock Pick Reports - baoquankhu1.vn
Can Xenetic Biosciences Inc. stock deliver strong Q4 earnings2025 Retail Activity & Safe Swing Trade Setup Alerts - mfd.ru
Investor Mood: Whats the outlook for Xenetic Biosciences Incs sectorWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Trend Report: Whats the profit margin of Xenetic Biosciences Inc2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Aug PreEarnings: Can Xenetic Biosciences Inc maintain sales growthWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Support Test: Is National Energy Services Reunited Corp gaining market shareMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Can Xenetic Biosciences Inc. be recession proofGDP Growth & Growth Focused Stock Pick Reports - mfd.ru
How cyclical is Xenetic Biosciences Inc.’s revenue streamEarnings Overview Report & Smart Money Movement Tracker - mfd.ru
Is Xenetic Biosciences Inc. stock undervalued right nowRate Cut & Real-Time Price Movement Reports - mfd.ru
Xenetic Biosciences appoints James Parslow as interim CEO - Intellectia AI
Renaissance holds 7.79% of Xenetic Biosciences (XBIO) shares - Stock Titan
Aug Drivers: Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Long-Term Safe Investment Plans - baoquankhu1.vn
Xenetic Biosciences Inc (XBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.77%
大文字化:
|
ボリューム (24 時間):